CGEN:NASDAQ
컴퓨젠
US$3.10
arrow_upward
+6.16%(+0.18) 1D
US$3.14
arrow_upward
+1.29% (+0.040)bedtime시간 외 거래
휴장: 4월 24일, 오후 4시 0분 1초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoCGEN의 주요 통계 생성 중...
시가
US$3.00
고가
US$3.24
저가
US$2.95
시가총액
2.93억
평균 거래량
35.22만
거래량
124.84만
주가수익률
8.23
52주 최고가
US$3.24
52주 최저가
US$1.23
EPS
US$0.38
베타
2.77
유통 주식수
9455.30만
직원 수
75
뉴스 기사
웹 소스 기반
프로필
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
컴퓨젠에 관한 정보